相关实验视频

Updated: Jul 3, 2025

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

循环的癌症特异性CD8T细胞频率与默克尔细胞癌中PD-1阻塞的反应有关

Thomas Pulliam¹, Saumya Jani², Lichen Jing³

¹Division of Dermatology, Department of Medicine, University of Washington, Seattle, WA 98109, USA.

Cell reports. Medicine

|February 10, 2024

概括

识别癌症特异性T细胞是癌症免疫生物学的关键. 在免疫治疗前,循环的默克尔细胞多细胞瘤病毒 (MCPyV) 特定的CD8T细胞的较高水平预测了病毒驱动的默克尔细胞癌 (MCC) 的更好的生存率.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
病毒学病毒学

背景情况:

识别癌症特异性T细胞对于理解癌症免疫生物学和开发有效的免疫疗法至关重要.
默克尔细胞多细胞病毒 (MCPyV) 与大多数默克尔细胞癌 (MCC) 有关,为病毒特异性T细胞识别提供了标.

研究的目的:

研究MCC患者中MCPyV特异性T细胞的作用和特征.
确定MCPyV特异性CD8T细胞频率与临床结果之间的关联,特别是对抗PD-1治疗的反应.

主要方法:

使用MCPyV-HLA-I多元仪和26色流细胞计来研究27名MCC患者的T细胞.
采用单细胞转录组学和T细胞受体 (TCR) 测序来进行深入的细胞分析.
进行了前性临床试验,评估在抗PD-1治疗前和治疗期间的T细胞频率.

主要成果:

在抗PD-1治疗前,循环中MCPyV特异性CD8 T细胞频率较高与2年无复发存活率 (75%对0%) 强烈相关.
内T细胞频率与治疗反应没有显著的关联.
与内细胞相比,循环T细胞表现出增强的干细胞/记忆和减少的疲劳特征.

结论:

循环中的癌症特异性CD8 T细胞可能是预测MCC中抗PD-1疗法的反应的重要生物标志物.
增加或动员这些循环T细胞的策略可能会改善病毒驱动癌症患者的治疗结果.

关键词:

在 HLA-I 的情况下,梅克尔细胞癌瘤是什么?默克尔细胞多聚马病毒获得的电阻获得的电阻这是一种抗PD-1药物.特定于癌症的T细胞.这就是尼沃卢马布 (nivolumab).主要电阻的主要电阻.皮肤癌是皮肤癌.

更多相关视频

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...